50242-583Level 3
Xofluza (BALOXAVIR MARBOXIL)
**Product type:** Human Prescription Drug
**Active ingredient:** BALOXAVIR MARBOXIL
**Strength:** 40 mg/20mL
**Dosage form:** Granule, For Solution
**Route:** Oral
**Labeler:** Genentech, Inc.
**Marketing category:** NDA (NDA214410)
**Pharmacologic class:** Chelating Activity [MoA], Polymerase Acidic Endonuclease Inhibitor [EPC], Polymerase Acidic Endonuclease Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/50242-583Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.